It was finally observed that hesperidin reduced inflammation and oxidative stress in CES-induced COPD mice and was linked to the SIRT1/PGC-1/NF-B signaling axis, suggesting a potentially novel approach to the treatment of COPD [27]. This evidence concerns the gene SIRT1 and chronic obstructive pulmonary disease.